Sabir S, Hongsibsong S, Chuljerm H, Parklak W, Ounjaijean S, Fakfum P
PeerJ. 2025; 13:e19047.
PMID: 40028207
PMC: 11871891.
DOI: 10.7717/peerj.19047.
Lin A, Mertens A, Rahman M, Tan S, Ilyasova D, Spasojevic I
Nat Commun. 2024; 15(1):3572.
PMID: 38670986
PMC: 11053067.
DOI: 10.1038/s41467-024-47896-z.
Rose D, Bentley L, Maity A, Maguire R, Planchart A, Spasojevic I
Heliyon. 2024; 10(3):e25578.
PMID: 38356491
PMC: 10865309.
DOI: 10.1016/j.heliyon.2024.e25578.
Song Q, Chen Y, Ma J, Zhou W, Song J, Wu C
Clin Cosmet Investig Dermatol. 2023; 16:3181-3191.
PMID: 37941849
PMC: 10631377.
DOI: 10.2147/CCID.S433280.
Miyazaki Y, Nakamura T, Takenouchi S, Hayashi A, Omori K, Murata T
PLoS One. 2021; 16(1):e0245292.
PMID: 33503019
PMC: 7840041.
DOI: 10.1371/journal.pone.0245292.
Alterations in plasma triglycerides and ceramides: links with cardiac function in humans with type 2 diabetes.
Peterson L, Jiang X, Chen L, Goldberg A, Farmer M, Ory D
J Lipid Res. 2020; 61(7):1065-1074.
PMID: 32393551
PMC: 7328042.
DOI: 10.1194/jlr.RA120000669.
Urine gastrin-releasing peptide in the first week correlates with bronchopulmonary dysplasia and post-prematurity respiratory disease.
Voynow J, Fisher K, Sunday M, Cotten C, Hamvas A, Hendricks-Munoz K
Pediatr Pulmonol. 2020; 55(4):899-908.
PMID: 31995668
PMC: 7071969.
DOI: 10.1002/ppul.24665.
Mass Spectrometry in Advancement of Redox Precision Medicine.
Chen X, Lee J, Wu H, Tsang A, Furdui C
Adv Exp Med Biol. 2019; 1140:327-358.
PMID: 31347057
PMC: 9236553.
DOI: 10.1007/978-3-030-15950-4_19.
Effects of 2 years of caloric restriction on oxidative status assessed by urinary F2-isoprostanes: The CALERIE 2 randomized clinical trial.
Ilyasova D, Fontana L, Bhapkar M, Pieper C, Spasojevic I, Redman L
Aging Cell. 2018; 17(2).
PMID: 29424490
PMC: 5847862.
DOI: 10.1111/acel.12719.
Cross-Classification of Human Urinary Lipidome by Sex, Age, and Body Mass Index.
Okemoto K, Maekawa K, Tajima Y, Tohkin M, Saito Y
PLoS One. 2016; 11(12):e0168188.
PMID: 27973561
PMC: 5156423.
DOI: 10.1371/journal.pone.0168188.
The isoprostanes--25 years later.
Milne G, Dai Q, Roberts 2nd L
Biochim Biophys Acta. 2014; 1851(4):433-45.
PMID: 25449649
PMC: 5404383.
DOI: 10.1016/j.bbalip.2014.10.007.
A metabolic biosignature of early response to anti-tuberculosis treatment.
Mahapatra S, Hess A, Johnson J, Eisenach K, DeGroote M, Gitta P
BMC Infect Dis. 2014; 14:53.
PMID: 24484441
PMC: 3918231.
DOI: 10.1186/1471-2334-14-53.
Effect of dietary advanced glycation end products on postprandial appetite, inflammation, and endothelial activation in healthy overweight individuals.
Poulsen M, Bak M, Andersen J, Monosik R, Giraudi-Futin A, Holst J
Eur J Nutr. 2013; 53(2):661-72.
PMID: 23929260
DOI: 10.1007/s00394-013-0574-y.
Quantification of fatty acid oxidation products using online high-performance liquid chromatography tandem mass spectrometry.
Levison B, Zhang R, Wang Z, Fu X, DiDonato J, Hazen S
Free Radic Biol Med. 2013; 59:2-13.
PMID: 23499838
PMC: 3772641.
DOI: 10.1016/j.freeradbiomed.2013.03.001.
Systemic oxidative stress, as measured by urinary allantoin and F(2)-isoprostanes, is not increased in Down syndrome.
Tolun A, Scarbrough P, Zhang H, McKillop J, Wang F, Kishnani P
Ann Epidemiol. 2012; 22(12):892-4.
PMID: 23063134
PMC: 3508197.
DOI: 10.1016/j.annepidem.2012.09.005.
Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI.
Ilyasova D, Wang F, Spasojevic I, Base K, DAgostino Jr R, Wagenknecht L
Obesity (Silver Spring). 2012; 20(10):2147-50.
PMID: 22836686
PMC: 3458154.
DOI: 10.1038/oby.2012.170.
Systemic markers of oxidative status and colorectal adenomatous polyps.
Siamakpour-Reihani S, Scarbrough P, Wang F, Spasojevic I, Base K, Sedjo R
Ann Epidemiol. 2012; 22(8):587-91.
PMID: 22695388
PMC: 3396712.
DOI: 10.1016/j.annepidem.2012.05.001.
Urinary biomarkers of oxidative status.
Ilyasova D, Scarbrough P, Spasojevic I
Clin Chim Acta. 2012; 413(19-20):1446-53.
PMID: 22683781
PMC: 3424057.
DOI: 10.1016/j.cca.2012.06.012.
Isoprostanes and asthma.
Voynow J, Kummarapurugu A
Biochim Biophys Acta. 2011; 1810(11):1091-5.
PMID: 21596100
PMC: 3192308.
DOI: 10.1016/j.bbagen.2011.04.016.